Dealing room buzz: Cadila, Indoco, Aurobindo, Crompton Greaves
Dealers are expecting action in Cadila Health after Nomura upgraded it to 'Buy' from 'Neutral' and raised target price to Rs 874.

Cadila Health: Dealers are expecting action in the stock after Nomura upgraded it to 'Buy' from 'Neutral' and raised target price to Rs 874.
The stock was at Rs 734.90, up 0.52 per cent, on the BSE. It touched a high of Rs 743 and a low of Rs 731.40 in trade today.
Indoco Remedies: Desks are indicating HNI accumulation in stock. Sales team of domestic brokerage pushing stock, say dealers.
The stock was at Rs 105.80, down 1.95 per cent, on the BSE. It touched a high of Rs 109 and a low of Rs 105.80 in trade today.
Aurobindo Pharma: DIIs are looking to book profits in the counter, say dealers.
The stock was at Rs 304.25, up 0.51 per cent, on the BSE. It touched a high of Rs 305.70 and a low of Rs 290.65 in trade today.
Hero MotoCorp: Strong FII interest seen in the stock after CLSA upgrade, say dealers.
The stock was at Rs 2,102, up 2.49 per cent, on the BSE. It touched a high of Rs 2,114.55 and a low of Rs 2,057 in trade today.
Crompton Greaves: PE Funds may invest Rs 960 crore in Avantha Holding. Funds will be used to cut promoter pledge. Dealers suggest buying for positional trade.
The stock was at Rs 129.45, up 1.85 per cent, on the BSE. It touched a high of Rs 131.15 and a low of Rs 127.50 in trade today.
Biocon: Desks indicate DII buying in the stock
The stock was at Rs 403.55, up 2.99 per cent, on the BSE. It touched a high of Rs 405.70 and a low of Rs 390.90 in trade today.
(Disclaimer: The above report is based on market buzz and information given by dealers. Please consult your financial advisor before taking any position in the stocks mentioned.)
Download ET Markets APP